Hypertension Scientific Sessions 2020 is supported by independent medical education grants from Medtronic and Chiesi USA, Inc.
Thursday
10:00 am11:30 am (CDT) Sep 10, 2020

Clinical | Angiotensin Degrading Enzymes and Their Therapeutic Potential


Access Sessions

Moderator: Daniel C. Batlle, MD, FAHA, Chicago, Illinois

10:00 am

Novel Short ACE2 Variants  

Jan A. Wysocki, MD, PhD, Chicago, Illinois

10:30 am

Neprilysin Inhibitors

Mark C. Chappell, PhD, FAHA, Winston-Salem, North Carolina

11:00 am         

Aminopeptidase A Inhibition

Catherine Llorens-Cortes, PhD, Paris, France